Country: Malta
Language: English
Source: Medicines Authority
PHENINDIONE
Mercury Pharma Group Limited
B01AA02
PHENINDIONE
TABLET
PHENINDIONE 50 milligram(s)
POM
ANTITHROMBOTIC AGENTS
Authorised
2006-08-14
PACKAGE LEAFLET: INFORMATION FOR THE USER PHENINDIONE 10 MG TABLETS, PHENINDIONE 25 MG TABLETS, PHENINDIONE 50 MG TABLETS 3. HOW TO TAKE PHENINDIONE TABLETS Always take Phenindione tablets exactly as your doctor has told you. Read the label to see how many Phenindione tablets to take, and how often to take them. Check with your doctor or pharmacist if you are not sure. The following dose recommendations are for ADULTS ONLY. The recommended dose for Phenindione tablets 10 mg is: • usual starting dose of 200 mg (20 TABLETS) on the first day • after the first day the dose is usually reduced to 100 mg (10 TABLETS) a day. The recommended dose for Phenindione tablets 25 mg is: • usual starting dose of 200 mg (8 TABLETS) on the first day • after the first day the dose is usually reduced to 100 mg (4 TABLETS) a day. The recommended dose for Phenindione tablets 50 mg is: • usual starting dose of 200 mg (4 TABLETS) on the first day • after the first day the dose is usually reduced to 100 mg (2 TABLETS) a day. From the THIRD DAY OF TREATMENT, the doctor will adjust your dose up or down depending on the results of a blood test which will be performed at the start and at regular intervals during your treatment. HOW TO TAKE PHENINDIONE TABLETS • Swallow the tablets whole with a drink of water • Try to take the tablets at the same time each day • Do not take more tablets than the doctor tells you to. This product is not suitable for use in children. If you have to go to another doctor, to hospital or to a dentist, tell them that you are being treated with Phenindione tablets and ask them to contact your own doctor. IF YOU TAKE MORE PHENINDIONE TABLETS THAN YOU SHOULD If you take too many Phenindione tablets, tell your doctor or go to Read the complete document
Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dindevan 50mg tablets Phenindione Tablets 50mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 50mg phenindione 3 PHARMACEUTICAL FORM Tablet 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Dindevan (Phenindione BP) is a synthetic anticoagulant which acts by interfering with the formation of factors II, VII, IX and X. It produces its effect in 36-48 hours after the initial dose; the effect wanes over a period of 48-72 hours after Dindevan is stopped. Anticoagulant therapy can be initiated with Heparin and Dindevan together. Anticoagulant therapy in the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation. Prophylaxis after insertion of prosthetic heart valves. Prophylaxis and treatment of venous thrombosis and pulmonary embolism. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Dosage: Adults: Initial loading dose of 200mg, followed on the second day by a dose of 100mg. Dosage must be adjusted from the third day, dependent on the results of the appropriate coagulation tests. Note: Concomitant heparin therapy affects the results of control tests, and heparin should be discontinued at least 6 hours before the first control test is undertaken. Control tests must be undertaken at regular intervals and the dosage adjusted according to the results of the tests. A maintenance dose of 50-150mg/day is satisfactory in most patients, but a "resistant" patient may need 200mg/day or more. A "sensitive" patient may need less than 50mg/day. Method of a Read the complete document